New Key Statistics Module, Z-Score and F-Score
NAS:FBIO Key Ratios
| Market Cap $ M | 37.24 |
| Enterprise Value $ M | 38.11 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.57 |
| Price/Sales | 0.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 85.00 |
| EPS (TTM) $ | -6.10 |
| Beneish M-Score | -1.01 |
| 10-y EBITDA Growth Rate % | -5.10 |
| 5-y EBITDA Growth Rate % | 8.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.30 |
| EV-to-EBITDA | -0.32 |
| PEG | -- |
| Shares Outstanding M | 19.92 |
| Net Margin (%) | -64.05 |
| Operating Margin % | -141.04 |
| Pre-tax Margin (%) | -161.56 |
| Quick Ratio | 1.21 |
| Current Ratio | 1.33 |
| ROA % (ttm) | -29.41 |
| ROE % (ttm) | -229.94 |
| ROIC % (ttm) | -160.87 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.72 |
FBIO Number of Guru Trades
FBIO Volume of Guru Trades
Gurus Latest Trades with NAS:FBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fortress Biotech Inc Insider Transactions
No Available Data
News about NAS:FBIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers